Is Novavax Stock a Buy Now?

10:07am, Thursday, 20'th Jul 2023
Novavax recently scored an important win that should help improve its cash flow. Still, the company faces many issues that make its prospects rather bleak.
Novavax will see an influx of cash from Canada due to canceled COVID vaccines. The business' core fundamentals remain shaky, however, and that may not change.
Novavax invested heavily in the development of COVID-19 vaccines that are now less in demand. This year's top line is projected to shrink 31%.
Pfizer, Moderna and Novavax have not disclosed the exact pricing of their new vaccines, which will target the circulating omicron subvariant XBB.1.5.
Novavax (NVAX) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that ma

Is This a Good Sign for Novavax?

02:30pm, Tuesday, 11'th Jul 2023
Novavax has struggled since it fell behind in the coronavirus vaccine race. An amendment to its deal with Canada is set to bring in $350 million this year.
Novavax (NVAX) is set to receive $350M from the Canadian government for forfeited Covid-19 vaccine doses per an amendment to the original purchase agreement between the parties. The stock rises 30%.
Novavax is expecting $350 million from Canada after the country terminated its contract with the COVID-19 manufacturer, also Fox gets hit with an analyst downgrade following cord-cutting risks tied to
Shares of Novavax soared over 29% after the Canadian government agreed to pay the biotech firm almost $350 million for canceling delivery of some COVID-19 vaccines previously ordered.

Why Is Novavax (NVAX) Up 30% Today?

01:37pm, Monday, 10'th Jul 2023
Embattled biotechnology firm Novavax (NASDAQ: NVAX ) — which previously incurred serious business viability risks — received much-needed positive news. On Friday after market close, the Canadian g

Why Shares of Novavax Are Up Monday

12:12pm, Monday, 10'th Jul 2023
Novavax's only commercial product line is COVID-19 vaccines. The company will receive payment from Canada for unused COVID-19 shots.
In February, the company said there was 'substantial doubt' about its ability to continue operating through this year.
Canada's Covid shot settlement is a sign of hope for investors after Novavax raised doubts about its ability to stay in business earlier this year.
Novavax Inc said on Friday Canada will pay $349.6 million to settle the forfeiting of certain doses of its COVID-19 vaccine previously scheduled for delivery.
All three companies are working on updated vaccines for COVID. A new variant, XBB.1.5, led to a spike in COVID cases in China earlier this year.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE